Skip to main content
Equibles

Caption Management, LLC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,196,080
+$3,196,080 QoQ
Shares Held
36,000
Ownership
0.041%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#119
of 266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Derivatives in SYRE

reported options exposure · as of Jun 30, 2026
CallValue
$2,219,500
CallShares
25,000
PutValue
$15,421,086
PutShares
173,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. SYRE ranks #21 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in SYRE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,421,086 173,700
2026-06-30 $2,219,500 25,000
2026-06-30 $3,196,080 36,000
2026-03-31 $11,994,632 237,800
2025-12-31 $13,100,724 399,900
2025-09-30 $1,427,952 85,200
2025-09-30 $838,000 50,000
2025-06-30 $1,047,900 70,000
2025-06-30 $598,800 40,000